InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
0%
T+90 mean return
-10.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Rodman David Malcom, Chief Medical Officer. Insider active across 1 company, notably Mineralys Therapeutics, Inc.. In total, 42 disclosures have been recorded. Split: 0 buy · 5 sells. Total volume traded: €1.5m. History available since 10 August 2023. The latest transaction was disclosed on 11 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations42 total
2,171 shares@ US$16.000.0012% mcap1.9% of flowCommon StockSEC:0001672659-26-000027
2,171 shares@ US$16.000.0013% mcap1.9% of flowCommon StockSEC:0001672659-26-000027:0
6,348 shares@ US$1.080.0002% mcap0.4% of flowCommon StockSEC:0001933414-26-000058
6,348 shares@ US$1.080.0003% mcap0.4% of flowCommon StockSEC:0001933414-26-000058:0
6,349 shares@ US$1.080.4% of flowCommon StockSEC:0001672659-26-000011
6,349 shares@ US$1.080.0003% mcap0.4% of flowCommon StockSEC:0001672659-26-000011:0
3,542 shares@ US$10.202.0% of flowCommon StockSEC:0001672659-26-000006
3,542 shares@ US$10.200.0014% mcap2.0% of flowCommon StockSEC:0001672659-26-000006:0
2,170 shares@ US$16.001.9% of flowCommon StockSEC:0001672659-26-000004
2,170 shares@ US$16.000.0013% mcap1.9% of flowCommon StockSEC:0001672659-26-000004:0
10,053 shares@ US$1.080.6% of flowCommon StockSEC:0001672659-26-000002
10,053 shares@ US$1.080.0004% mcap0.6% of flowCommon StockSEC:0001672659-26-000002:0
10,369 shares@ US$43.01110.017% mcap24.6% of flowCommon StockSEC:0001933414-25-000128:0
10,369 shares@ US$43.011124.6% of flowCommon StockSEC:0001933414-25-000128
9,302 shares@ US$35.90040.013% mcap18.2% of flowCommon StockSEC:0001672659-25-000006:0
9,302 shares@ US$35.900418.2% of flowCommon StockSEC:0001672659-25-000006
11,366 shares@ US$15.28898.4% of flowCommon StockSEC:0001933414-25-000062:0
6,349 shares@ US$1.080.3% of flowCommon StockSEC:0001933414-25-000060:0
6,348 shares@ US$1.080.3% of flowCommon StockSEC:0001933414-25-000047:0
1,606 shares@ US$1.080.1% of flowCommon StockSEC:0001933414-25-000029:0
6,349 shares@ US$1.080.3% of flowCommon StockSEC:0001933414-25-000021:0
6,348 shares@ US$1.080.4% of flowCommon StockSEC:0001933414-25-000010:0
5,018 shares@ US$0.540.1% of flowCommon StockSEC:0001933414-25-000004:0
5,017 shares@ US$0.540.1% of flowCommon StockSEC:0001933414-24-000062:0
5,017 shares@ US$0.540.1% of flowCommon StockSEC:0001933414-24-000061:0
25 of 42 declarations
About Rodman David Malcom
Rodman David Malcom is the Chief Medical Officer of Mineralys Therapeutics, Inc. He oversees the company's medical and clinical initiatives.
